ATE500257T1 - Hydromorphinonzusammensetzungen - Google Patents

Hydromorphinonzusammensetzungen

Info

Publication number
ATE500257T1
ATE500257T1 AT08157739T AT08157739T ATE500257T1 AT E500257 T1 ATE500257 T1 AT E500257T1 AT 08157739 T AT08157739 T AT 08157739T AT 08157739 T AT08157739 T AT 08157739T AT E500257 T1 ATE500257 T1 AT E500257T1
Authority
AT
Austria
Prior art keywords
hydromorphone
hydroxy
dihydromorphone
salt
disclosed
Prior art date
Application number
AT08157739T
Other languages
English (en)
Inventor
William Harclerode
Robert Gault
Mark Sandison
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27389009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE500257(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE500257T1 publication Critical patent/ATE500257T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • External Artificial Organs (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
AT08157739T 1999-11-09 2000-11-09 Hydromorphinonzusammensetzungen ATE500257T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16436499P 1999-11-09 1999-11-09
US16453699P 1999-11-09 1999-11-09
US16450599P 1999-11-09 1999-11-09

Publications (1)

Publication Number Publication Date
ATE500257T1 true ATE500257T1 (de) 2011-03-15

Family

ID=27389009

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08157739T ATE500257T1 (de) 1999-11-09 2000-11-09 Hydromorphinonzusammensetzungen
AT00978498T ATE402937T1 (de) 1999-11-09 2000-11-09 Hydromorphinone and hydrocodeinone compositions and methods for their synthesis

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT00978498T ATE402937T1 (de) 1999-11-09 2000-11-09 Hydromorphinone and hydrocodeinone compositions and methods for their synthesis

Country Status (10)

Country Link
US (2) US6512117B1 (de)
EP (3) EP2003134B1 (de)
JP (1) JP4886953B2 (de)
AT (2) ATE500257T1 (de)
AU (1) AU1595701A (de)
CA (3) CA2854796A1 (de)
DE (2) DE60039711D1 (de)
ES (1) ES2309001T5 (de)
MX (1) MXPA02004678A (de)
WO (1) WO2001034608A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2389235C (en) 1999-10-29 2007-07-17 Euro-Celtique, S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
EP2283829A1 (de) 2000-10-30 2011-02-16 Euro-Celtique S.A. Hydrocodon-Formulierungen mit gesteuerter Freisetzung
US7323565B2 (en) 2002-11-11 2008-01-29 Mallinckrodt Inc. Method for the catalytic production of hydrocodone and hydromorphone
US7321038B2 (en) 2002-11-11 2008-01-22 Mallinckrodt Inc. Method for the catalytic production of hydrocodone and hydromorphone
WO2005016930A2 (en) * 2003-08-08 2005-02-24 Euro-Celtique, S.A. Methods for detecting morphinone
SK286047B6 (sk) * 2004-04-13 2008-01-07 Zentiva, A. S. Spôsob prípravy derivátov 4,5alfa-epoxy-6-oxomorfínanu
US6946556B1 (en) 2004-05-21 2005-09-20 Acura Pharmaceuticals, Inc. Preparation of opioid analgesics by a one-pot process
US7348430B2 (en) 2005-01-21 2008-03-25 Acura Pharmaceuticals, Inc. Production of opioid analgesics
MX2007011752A (es) * 2005-03-28 2007-11-21 Mallinckrodt Inc Metodo para la produccion catalitica de hidrocodona, hidromorfona y derivados de las mismas.
AU2006236379A1 (en) 2005-04-18 2006-10-26 Noramaco Inc. Hydromorphone polymorphs
US20100073766A1 (en) * 2005-10-26 2010-03-25 Angros Lee H Microscope slide testing and identification assembly
US20080069891A1 (en) 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
US7399859B1 (en) 2007-02-06 2008-07-15 Cody Laboratories Inc. Method for catalytic preparation of hydromorphone and hydrocodone
US20080206883A1 (en) * 2007-02-26 2008-08-28 Cody Laboratories, Inc. Hplc method for separation and detection of hydromorphone and related opioid pharmacophores
US8962841B2 (en) 2007-06-29 2015-02-24 Brock University Methods for one-pot N-demethylation/N-functionalization of morphine and tropane alkaloids
US7999104B2 (en) 2007-06-29 2011-08-16 Brock University Methods for one-pot N-demethylation/N-acylation of morphine and tropane alkaloids
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
GB0802351D0 (en) * 2008-02-08 2008-03-12 Owen Mumford Ltd Injection devices
PL2417139T3 (pl) * 2009-04-09 2016-09-30 Wytwarzanie nasyconych związków ketonowo-morfinanowych za pomocą katalitycznej izomeryzacji
WO2010118274A1 (en) * 2009-04-09 2010-10-14 Mallinckrodt Inc. Preparation of 6-keto, 3-alkoxy morphinans
WO2010118275A1 (en) * 2009-04-09 2010-10-14 Mallinckrodt Inc. Preparation of saturated ketone morphinan compounds
US8383815B2 (en) 2009-09-21 2013-02-26 Mallinckrodt Llc Heterogeneous ruthenium metal catalyst for the production of hydrocodone, hydromorphone or a derivative thereof
MX2012012991A (es) 2010-05-11 2012-11-30 Cima Labs Inc Formas de dosificacion oral de liberacion prolongada resistentes al alcohol y que contienen metoprolol.
ES2613403T3 (es) 2011-05-06 2017-05-24 Brock University Proceso de preparación de análogos de la morfina mediante N-desmetilación/funcionalización catalizada por metal y transferencia de grupo intramolecular
TWI560170B (en) * 2011-12-06 2016-12-01 Lundbeck & Co As H Process for recovery of nalmefene hydrochloride
US9155734B2 (en) 2012-03-07 2015-10-13 Mallinckrodt Llc Stability of hydromorphone hydrochloride solutions
CN103408553B (zh) * 2013-08-20 2016-02-03 宜昌人福药业有限责任公司 一种氢吗啡酮酸式盐的精制工艺
PL3102576T3 (pl) 2014-02-03 2019-12-31 Vitae Pharmaceuticals, Llc Dihydropirolopirydynowe inhibitory ror-gamma
UA118989C2 (uk) 2014-10-14 2019-04-10 Вітае Фармасьютікалс, Інк. Дигідропіролопіридинові інгібітори ror-гамма
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
WO2017024018A1 (en) 2015-08-05 2017-02-09 Vitae Pharmaceuticals, Inc. Modulators of ror-gamma
MA53943A (fr) 2015-11-20 2021-08-25 Vitae Pharmaceuticals Llc Modulateurs de ror-gamma
TWI757266B (zh) 2016-01-29 2022-03-11 美商維它藥物有限責任公司 ＲＯＲ－γ調節劑
US9481674B1 (en) 2016-06-10 2016-11-01 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
US10081636B2 (en) 2016-07-08 2018-09-25 Cody Laboratories, Inc. Method for catalytic preparation of hydromorphone, hydrocodone, and other opiates
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF ROR GAMMA
CN115716826A (zh) 2017-07-24 2023-02-28 生命医药有限责任公司 RORγ的抑制剂
CN108164540B (zh) * 2017-12-14 2019-08-13 宜昌人福药业有限责任公司 一种合成氢吗啡酮的方法
IL302416A (en) * 2020-11-02 2023-06-01 Rhodes Tech A process for purifying noroxymorphone
US20240043447A1 (en) 2020-11-13 2024-02-08 Ferrer Internacional, S.A. Synthesis of hydromorphone base

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB285404A (de) *
DE260233C (de)
DE365683C (de) 1921-03-22 1922-12-22 Knoll & Co Chem Fab Verfahren zur Darstellung von Ketoderivaten der Morphinreihe
DE607931C (de) † 1934-01-26 1935-01-11 Chemische Fabriken Verfahren zur Darstellung von Dihydromorphinonen
US2544291A (en) 1949-04-05 1951-03-06 New York Quinine And Chemical Alkaloid manufacture
US2628962A (en) 1949-10-20 1953-02-17 Mallinckrodt Chemical Works Method for preparing dihydrocodeinone, dihydromorphinone, and codeinone
US2654756A (en) * 1949-10-20 1953-10-06 Mallinckrodt Chemical Works Process of preparing codeinone, dihydrocodeinone, and dihydromorphinone
US2649454A (en) 1951-08-20 1953-08-18 Univ California Method for preparing dihydromorphinone, dihydrocodeinone, and dihydropseudocodeinone
GB9616253D0 (en) * 1996-08-01 1996-09-11 Johnson Matthey Plc Preparation of narcotic analgesics

Also Published As

Publication number Publication date
EP2003134A3 (de) 2009-02-25
EP2338891A3 (de) 2011-10-26
DE60039711D1 (en) 2008-09-11
US20030045720A1 (en) 2003-03-06
CA2674424C (en) 2012-10-02
JP2003513980A (ja) 2003-04-15
ES2309001T3 (es) 2008-12-16
MXPA02004678A (es) 2005-10-05
WO2001034608A1 (en) 2001-05-17
ES2309001T5 (es) 2011-12-28
US6589960B2 (en) 2003-07-08
CA2389193A1 (en) 2001-05-17
EP2003134A2 (de) 2008-12-17
AU1595701A (en) 2001-06-06
JP4886953B2 (ja) 2012-02-29
ATE402937T1 (de) 2008-08-15
US6512117B1 (en) 2003-01-28
CA2854796A1 (en) 2001-05-17
EP1233966A1 (de) 2002-08-28
EP1233966B1 (de) 2008-07-30
DE60045695D1 (de) 2011-04-14
EP2338891A2 (de) 2011-06-29
CA2674424A1 (en) 2001-05-17
EP1233966B2 (de) 2011-10-19
EP2003134B1 (de) 2011-03-02

Similar Documents

Publication Publication Date Title
DE60045695D1 (de) Hydromorphinonzusammensetzungen
PH24199A (en) Derivatives of quinoline carboxylic acid,pharmaceutical composition containing same and process of preparing same
HU9401415D0 (en) Enzofuranyl- and -thiophenyl-alkane-carboxylic acid derivatives, pharmaceutical compositions contaning them, and process for producing them
ATE44954T1 (de) Carbostyrilderivat und verfahren zu seiner herstellung.
HUP0102084A2 (hu) Kinolinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
ATE302786T1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
DE69715211D1 (de) Verfahren zur herstellung von tetraazamakroringen
ATE100440T1 (de) Verfahren zur herstellung von n-methyl-3-(ptrifluoromethyl-phenoxy)-3-phenyl-propylamin und ihre salze.
ATE121094T1 (de) Verfahren zur herstellung von kolloidalen dispersionen von cerdioxid in alkoholischem medium.
PT1301526E (pt) Processo de oxidação para preparar o intermediário ácido 6.alfa.,9.alfa.-difluoro-11.beta.,17.alfa.-di-hidroxi-16.alfa.-metil androsta-1,4-dien-3-ona 17.beta.-carboxílico
DE3864636D1 (de) Amidverbindungen, verfahren zu ihrer herstellung und zusammensetzung zur aktivierung gastromotorischer funktionen.
ATE212849T1 (de) Langwirkende, injezierbare, parasitizide zubereitung und verfahren zu ihrer herstellung
DK543987A (da) Quinolinbaseret forbindelse, fremgangsmaade til fremstilling heraf samt anticancermiddel omfattende samme
EP0168921A3 (de) Chemische Verbindungen
ATE295368T1 (de) Verfahren zur herstellung 3-amino-gallensaurer derivate
EP1238704A3 (de) Katalysator enthaltend eine zyklische Imid-Verbindung und Verfahren zur Herstellung von organischen Verbindungen unter Verwendung des Katalysators
ATE236895T1 (de) Ringannelierte dihydropyrane, verfahren zur herstellung sowie deren verwendung
DE3781879D1 (de) Anthracyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3750335D1 (de) Verfahren zur herstellung eines gemisches aus chloraufweisenden verbindungen einschliesslich chlordioxyden.
ATE41919T1 (de) Verfahren zur herstellung von gegebenenfalls in 5-stellung halogenisierten 6-(nieder)-alkoxy-1naphthoes|urenund den entsprechenden estern.
DE60014103D1 (de) Verfahren zur herstellung von debromohymenialdisin und deren analogen
DE50202096D1 (de) Verfahren zur Herstellung von 5-Alkoxy-Oxazolen sowie von Pyridoxinen
JPS54151985A (en) Preparation of aminocarbostyril derivative
ATE145197T1 (de) Lagerstabile lösungen von carbonisiertem magnesiumethylat in ethanol sowie deren herstellung und verwendung
ATE275566T1 (de) Verfahren zur herstellung von 1,8-

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties